Cytometry Part B-Clinical Cytometry

Papers
(The median citation count of Cytometry Part B-Clinical Cytometry is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue highlights—January 202548
33
An uncommon case of acute megakaryoblastic leukemia with DDX3X :: MLLT10 30
28
Diagnostic workflow for X‐linked agammaglobulinemia integrating BTK expression and B‐cell maturation analysis by flow cytometry22
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells20
19
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease19
Issue highlights—September 202318
16
Issue Information16
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma15
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel14
Defining atypical chronic lymphocytic leukemia for reproducible diagnosis: implications of the work by Wang et al.14
Standardization of flow cytometric detection of antigen expression13
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia13
Issue Information12
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients12
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi12
Issue Information12
Issue Information11
Issue Information10
ROR1 expression in mature B lymphoid neoplasms by flow cytometry10
CD133 in T ‐lymphoblastic leukemia is preferentially expressed in early T 10
Issue Information9
Issue Information9
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric9
A novel flow cytometry approach to quantify malaria‐derived particles9
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR9
Effects of washing procedures on cell loss in different diagnostic flow cytometry sample types9
Integrating immune profiling and clinical features for early prediction of chronicity in pediatric immune thrombocytopenia9
Basophilic blast crisis of chronic myelogenous leukemia presenting de novo: Diagnostic contribution of flow cytometry9
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry8
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT8
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays7
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet7
SingletSeeker: An unsupervised clustering approach for automated singlet discrimination in cytometry7
International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories7
Issue Information6
6
Anti‐ CD38 VHH antibody ( JK36 ) reliably detects CD38 6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry6
Characterization of CD123 expression by mast cells in systemic mastocytosis with multicolor flow cytometry6
6
Implementation of a one‐tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine6
Monocyte maturation pattern by flow cytometry expression of CD64 , CD300e , and 6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis6
Quantifying gating heterogeneity in the Ogata score: Implications for reproducibility and score‐based diagnostics5
Editorial on IVD cellular assay validation5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Issue Information5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening5
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases5
Optimizing the diagnosis of chronic granulomatous disease using dihydrorhodamine‐123 assay: Lessons from a large monocentric cohort5
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories5
Plasmacytoid dendritic cell proliferation can be clonally related to early T‐cell precursor acute lymphoblastic leukemia5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry5
Quantifying interpretive contributions to analytical variability in clinical flow cytometry4
Flow cytometry‐based monitoring of chimeric antigen receptor ( CAR ) T cells: Reagent selection, assay design, and clinical utility4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma4
Issue Highlights—July 20254
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
Issue Information4
Exercise affects systemic basophil responses in humans: Applying an automated and modified basophil activation test ( mBAT ) in a field study4
Signal without noise: Practical antibody titration for platelet flow cytometry4
4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia4
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care4
Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia4
Stabilization of bronchoalveolar lavage cells for postponed flow cytometric analysis4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis4
Issue highlights—November 20244
3
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern3
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis3
Establishment of pediatric reference ranges for circulating naïve and memory T and B cell subsets guided by the human immunophenotyping consortium standardization initiative: A large, single center U.3
Issue Highlights—November 20253
Flow cytometry in the diagnosis of myelodysplastic syndromes3
3
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia3
Analysis of immunophenotypic changes in acute megakaryoblastic leukemia after treatment3
Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease3
Mature T‐cell leukemia/lymphoma with an NK ‐like immunophenotype: A report of 7 cases3
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions3
Highlights May 20263
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder3
Issue highlights—July 20243
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent3
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry3
Measurable residual disease by multicolor flow cytometry in acute myeloid leukemia: A comparison of peripheral blood and bone marrow3
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease3
Issue highlights—May 20233
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study3
Challenges and approaches in the diagnosis and differential diagnosis of atypical CLL : A response to ‘Defining atypical CLL2
Issue Information2
2
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma2
Establishment of a flow cytometric platelet crossmatching assay and its clinical application in platelet refractoriness2
Optimization and validation of a flow cytometry‐based HLA ‐ B27 assay on 2
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow2
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow2
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience2
Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia2
Issue Information2
Recommendations for using artificial intelligence in clinical flow cytometry2
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection2
Issue highlights—July 20232
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms2
Comment on “An unusual pattern observed upon the addition of CD79b to a flow‐Cytometry B‐cell Lymphoma panel” ( Cytometry B Cl2
Issue highlights—September 20242
Issue Information2
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy2
2
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS2
Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country1
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia1
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transp1
AI in flow cytometry: Current applications and future directions1
Issue Information1
Issue highlights—November 20221
De novo acute myeloid leukemia harboring concurrent CBFA2T3 :: 1
Detailed analysis of TRBC1 distribution in T‐cell subsets and its application in T‐cell clonality assessment1
Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders1
Therapy‐related B ‐lymphoblastic leukemia/lymphoma with MYC 1
The role of CD20+ T cells: Insights in human peripheral blood1
Circulating monocyte partitioning and its alteration in hematological chronic neoplasms1
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry1
Issue Highlights—September 20221
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry1
Automation in flow cytometry: Guidelines and review of systems1
Immunophenotypic characteristics of plasma cells in POEMS syndrome1
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands1
Authors' Response to Letter from Khanolkar and Ahmed concerning our article “An unusual pattern observed upon the addition of CD79b to a flow cytomet1
Issue highlights—July 20261
CD200 expression in CD4 + T‐cells: Diagnostic implications across T‐cell lymphomas1
To fret over FRET : Unintended fluorescence energy transfer artifacts and their implications for flow cytometry panel design and interpretation as hi1
Artificial Intelligence Issue Highlights1
Noel Warner Ph.D.1
“What are we measuring?” reconsidering the biological identity and clinical interpretation of malaria‐derived particles1
Bridging the implementation gap in AI ‐assisted flow cytometry1
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry1
Standardizing stem cell enumeration: A methodological comparison of single and dual flow cytometry platforms1
0.22687482833862